These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26270769)

  • 1. Potential Use of Thioalkylated Mannose-Modified Dendrimer (G3)/α-Cyclodextrin Conjugate as an NF-κB siRNA Carrier for the Treatment of Fulminant Hepatitis.
    Motoyama K; Mitsuyasu R; Akao C; Abu Hashim II; Sato N; Tanaka T; Higashi T; Arima H
    Mol Pharm; 2015 Sep; 12(9):3129-36. PubMed ID: 26270769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential use of fucose-appended dendrimer/α-cyclodextrin conjugates as NF-κB decoy carriers for the treatment of lipopolysaccharide-induced fulminant hepatitis in mice.
    Akao C; Tanaka T; Onodera R; Ohyama A; Sato N; Motoyama K; Higashi T; Arima H
    J Control Release; 2014 Nov; 193():35-41. PubMed ID: 25020038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and evaluation of thioalkylated mannose-modified dendrimer (G3)/α-cyclodextrin conjugates as antigen-presenting cell-selective siRNA carriers.
    Motoyama K; Mitsuyasu R; Akao C; Tanaka T; Ohyama A; Sato N; Higashi T; Arima H
    AAPS J; 2014 Nov; 16(6):1298-308. PubMed ID: 25236864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of gene transfer activity mediated by mannosylated dendrimer/alpha-cyclodextrin conjugate (generation 3, G3).
    Arima H; Chihara Y; Arizono M; Yamashita S; Wada K; Hirayama F; Uekama K
    J Control Release; 2006 Nov; 116(1):64-74. PubMed ID: 17083992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential use of lactosylated dendrimer (G3)/α-cyclodextrin conjugates as hepatocyte-specific siRNA carriers for the treatment of familial amyloidotic polyneuropathy.
    Hayashi Y; Mori Y; Yamashita S; Motoyama K; Higashi T; Jono H; Ando Y; Arima H
    Mol Pharm; 2012 Jun; 9(6):1645-53. PubMed ID: 22510029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
    Arima H; Yoshimatsu A; Ikeda H; Ohyama A; Motoyama K; Higashi T; Tsuchiya A; Niidome T; Katayama Y; Hattori K; Takeuchi T
    Mol Pharm; 2012 Sep; 9(9):2591-604. PubMed ID: 22873579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of siRNA complexes with polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) on endogenous gene expression.
    Arima H; Tsutsumi T; Yoshimatsu A; Ikeda H; Motoyama K; Higashi T; Hirayama F; Uekama K
    Eur J Pharm Sci; 2011 Oct; 44(3):375-84. PubMed ID: 21896329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugar-appended polyamidoamine dendrimer conjugates with cyclodextrins as cell-specific non-viral vectors.
    Arima H; Motoyama K; Higashi T
    Adv Drug Deliv Rev; 2013 Aug; 65(9):1204-14. PubMed ID: 23602906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cells.
    Arima H; Arizono M; Higashi T; Yoshimatsu A; Ikeda H; Motoyama K; Hattori K; Takeuchi T; Hirayama F; Uekama K
    Cancer Gene Ther; 2012 May; 19(5):358-66. PubMed ID: 22402627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA).
    Tsutsumi T; Hirayama F; Uekama K; Arima H
    J Control Release; 2007 Jun; 119(3):349-59. PubMed ID: 17477999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dendrimer/cyclodextrin conjugates as gene transfer carriers on nitric oxide production from macrophages.
    Motoyama K; Sako A; Ibrahim Abu Hashim I; Higashi T; Arima H
    J Pharm Pharmacol; 2016 May; 68(5):598-607. PubMed ID: 26076676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of polyamidoamine dendrimer conjugate with glucuronylglucosyl-β-cyclodextrin (G3) as a novel carrier for siRNA.
    Abdelwahab AF; Ohyama A; Higashi T; Motoyama K; Khaled KA; Sarhan HA; Hussein AK; Arima H
    J Drug Target; 2014 Dec; 22(10):927-34. PubMed ID: 25148608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro and In Vivo Tumor-Targeting siRNA Delivery Using Folate-PEG-appended Dendrimer (G4)/α-Cyclodextrin Conjugates.
    Ohyama A; Higashi T; Motoyama K; Arima H
    Bioconjug Chem; 2016 Mar; 27(3):521-32. PubMed ID: 26715308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of gene delivery mediated by mannosylated dendrimer/alpha-cyclodextrin conjugates.
    Wada K; Arima H; Tsutsumi T; Chihara Y; Hattori K; Hirayama F; Uekama K
    J Control Release; 2005 May; 104(2):397-413. PubMed ID: 15907588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/alpha-cyclodextrin conjugates (G2) into hepatocytes.
    Arima H; Yamashita S; Mori Y; Hayashi Y; Motoyama K; Hattori K; Takeuchi T; Jono H; Ando Y; Hirayama F; Uekama K
    J Control Release; 2010 Aug; 146(1):106-17. PubMed ID: 20678990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential use of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for short hairpin RNA-expressing plasmid DNA.
    Tsutsumi T; Hirayama F; Uekama K; Arima H
    J Pharm Sci; 2008 Aug; 97(8):3022-34. PubMed ID: 17932986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic delivery of transthyretin siRNA mediated by lactosylated dendrimer/α-cyclodextrin conjugates into hepatocyte for familial amyloidotic polyneuropathy therapy.
    Hayashi Y; Mori Y; Higashi T; Motoyama K; Jono H; Sah DW; Ando Y; Arima H
    Amyloid; 2012 Jun; 19 Suppl 1():47-9. PubMed ID: 22519861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evaluation of polyamidoamine dendrimer conjugate with PEG, α-cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in vivo.
    Hayashi Y; Higashi T; Motoyama K; Mori Y; Jono H; Ando Y; Arima H
    J Drug Target; 2013 May; 21(5):487-96. PubMed ID: 23570609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a siRNA carrier for the treatment of familial amyloidotic polyneuropathy.
    Anno T; Higashi T; Hayashi Y; Motoyama K; Jono H; Ando Y; Arima H
    J Drug Target; 2014 Dec; 22(10):883-90. PubMed ID: 25051178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo gene transfer by an optimized alpha-cyclodextrin conjugate with polyamidoamine dendrimer.
    Kihara F; Arima H; Tsutsumi T; Hirayama F; Uekama K
    Bioconjug Chem; 2003; 14(2):342-50. PubMed ID: 12643744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.